Neogen Corp is primarily active in the food safety and animal health industries.

The main competitors of Neogen Corp in the market include companies such as IDEXX Laboratories, Zoetis Inc., and Thermo Fisher Scientific Inc.

Neogen Corp, founded in 1982, is a leading global company specializing in food and animal safety solutions. Headquartered in Lansing, Michigan, Neogen is committed to developing innovative products for the agricultural, food, and pharmaceutical industries. With a diverse range of products and services, Neogen offers reliable and accurate diagnostic test kits, hygiene monitoring systems, and animal genomics solutions. They have built a solid reputation for their commitment to quality, customer service, and staying at the forefront of technological advancements. Neogen Corp's continuous dedication to improving food safety and animal health has made them a trusted and respected name in the industry.

Neogen Corp has achieved several significant milestones throughout its history. The company successfully developed and introduced rapid food and animal safety tests, revolutionizing the industry. They expanded their product portfolio to include diagnostics for human healthcare, veterinary medicine, and agricultural concerns globally. Neogen Corp's continuous innovations in genomics, biosecurity, and animal safety further propelled its growth. The company established strategic partnerships and collaborations to enhance its product offerings and market reach. Neogen Corp's commitment to quality, accuracy, and reliability has earned them a strong reputation with customers worldwide. With a track record of achievements, Neogen Corp continues to lead as a trusted provider of innovative solutions in the field of food and animal safety.

Neogen Corp is primarily present in several countries and regions around the world. These include the United States, Canada, Mexico, and various countries in Europe, such as Belgium, France, Germany, and the United Kingdom. Additionally, Neogen Corp has a strong presence in Asia, with operations in China and southeast Asian countries like Singapore. With its global reach, Neogen Corp continues to expand its presence and offer its innovative products and services to customers in diverse markets.

Neogen Corp is a company that values innovation, integrity, and commitment to quality. Their corporate philosophy revolves around providing solutions for the food and animal safety industries through advanced technology and dedicated research. With a focus on developing and marketing products to ensure the safety of food, feed, and animal health, Neogen Corp aims to be a trusted partner for agricultural, veterinary, and food processing industries. By consistently delivering high-quality products and services, Neogen Corp reinforces its commitment to the safety and well-being of both humans and animals, making it a reputable player in the industry.

Analysts currently set an average price target of 11,22 USD for the Neogen stock (median: 11,22 USD), implying -3,7 % versus the latest price. The consensus is based on 11 analyst ratings.

Neogen Koersdoelstellingen analisten 2026

11 analysts currently rate the Neogen stock: 7 recommend buying, 4 holding and 0 selling.

Neogen Koersdoelstellingen analisten 2026

Converted at the current exchange rate, the Neogen share trades at 10,07 EUR (11,65 USD).

The Neogen share (NEOG) is listed on 2 stock exchanges, including: NASDAQ (NEOG), Frankfurt (NG2.F).

The company Neogen Corp is a leading provider of food and animal health products. Its business model is focused on developing high-quality products and services that help improve food and animal health. The company is divided into two main areas: food and animal health. In the food sector, Neogen offers testing systems and diagnostic products that are used to monitor food safety and quality. Neogen's testing systems are used in food technology, animal feed control, and animal health. The products range from allergen-specific tests to detection methods for contamination or spoilage in food. In the animal health segment, the company offers a wide range of therapeutic and preventive products to promote animal health and performance. The product range includes products for the diagnosis and treatment of animals as well as medications, feed additives, and other products. Neogen Corp also offers services such as laboratory services and training. Neogen focuses on innovation and regularly invests in research and product development. The company works closely with leading universities and institutes to develop innovative products that meet the needs of customers. Product development focuses on creating effective solutions for animal health, preventing food contamination, and improving food quality. The company operates internationally and offers its products and services worldwide. Neogen has subsidiaries in Europe, Asia, and South America and works with distributors in over 60 countries. Neogen's global presence enables the company to meet the diverse needs of its customers in different countries and regions. In addition to its business activities, Neogen emphasizes its commitment to sustainability and social responsibility. The company is dedicated to promoting environmental and food quality, as well as the safety and health of animals. It also works to develop and improve its products and services to promote these goals. Neogen Corp is a leading provider of food and animal health products. The company offers a wide range of products and services aimed at improving food and animal health standards. The company relies on innovation and investments in research and development to create high-quality solutions for customers around the world. With a strong global presence and a commitment to sustainability and social responsibility, Neogen is well positioned to drive growth in these critical areas of the economy.

De omzet van Neogen bedraagt 870,40 Miljoen USD. Deze cijfers zijn gebaseerd op huidige financiële gegevens en weerspiegelen de bedrijfsresultaten van het bedrijf.

De winst van Neogen bedraagt -7,90 Miljoen USD. De nettowinst weerspiegelt de rentabiliteit van het bedrijf na aftrek van alle kosten.

De koers-winstverhouding (P/E) van Neogen bedraagt momenteel -321,04. De P/E-ratio vergelijkt de huidige aandeelkoers met de winst per aandeel en helpt beleggers de waardering van het Neogen-aandeel in te schatten.

De koers-omzetverhouding (P/S) van Neogen bedraagt momenteel 2,91. De P/S-ratio vergelijkt de marktkapitalisatie met de jaarlijkse opbrengsten en dient als waarderingsmaatstaf voor het Neogen-aandeel.

De Eulerpool Kwaliteitsscore voor Neogen is 3/10.

De ISIN van Neogen is US6404911066. De ISIN (International Securities Identification Number) is een wereldwijd unieke identificatie voor wertpapieren.

De WKN van Neogen is 883297. De WKN (Wertpapierkennnummer) is een zescijferig Duits identificatienummer voor wertpapieren.

Het tickersymbool van Neogen is NEOG. Onder dit beurstickersymbool wordt het Neogen-aandeel op de beurs verhandeld.

Neogen betaalde de afgelopen 0 jaar elk jaar dividend.

Neogen wordt toegewezen aan de sector 'Gezondheid'.

De dividenden van Neogen worden in USD uitgekeerd.